Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Genetics|June 1, 2023
LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancerMarco Antonio Fonseca-Montaño, Mireya Cisneros-Villanueva, Isabelle Coales, et al.
Scientific Reports|January 17, 2024
LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancerMireya Cisneros-Villanueva, Marco Antonio Fonseca-Montaño, Magdalena Ríos-Romero, et al.
BMC Cancer|October 30, 2024
The lncRNA AFAP1-AS1 is upregulated in metastatic triple-negative breast tumors and controls hypoxia-activated vasculogenic mimicry and angiogenesisAlejandra Paola García-Hernández, David Núñez Corona, Ángeles Carlos-Reyes, et al.
Hereditas|October 30, 2025
The microRNAs landscape of luminal B breast cancer cells in a three-dimensional microenvironmentStephanie I Nuñez-Olvera, Lorena Aguilar-Arnal, Jonathan Puente-Rivera, et al.
Cells|November 11, 2022
Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional MicroenvironmentStephanie I Nuñez-Olvera, Lorena Aguilar-Arnal, Mireya Cisneros-Villanueva, et al.
Cancers|May 28, 2022
Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer CellsYarely M Salinas-Vera, Jesús Valdés, Alfredo Hidalgo-Miranda, et al.
Scientific Reports|March 20, 2022
End-point RT-PCR based on a conservation landscape for SARS-COV-2 detectionArmando Cruz-Rangel, Laura Gómez-Romero, Mireya Cisneros-Villanueva, et al.
Scientific Reports|August 6, 2020
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtypeAlberto Cedro-Tanda, Magdalena Ríos-Romero, Sandra Romero-Córdoba, et al.
Scientific Reports|August 26, 2020
FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patientsMagdalena Ríos-Romero, Alberto Cedro-Tanda, Mónica Peña-Luna, et al.
Frontiers in Oncology|April 29, 2021
LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related GenesMireya Cisneros-Villanueva, Lizbett Hidalgo-Pérez, Alberto Cedro-Tanda, et al.
Pageof 2